Probiotic therapy alleviates SIBO but has no effect on liver disease

Researchers study use of probiotic therapy in patients with liver disease and SIBO

Oct 1, 2014 · 1 minute read

This research focused on the benefits of using probiotic therapy for patients with chronic liver disease, small intestinal bacterial overgrowth (SIBO) and intestinal permeability problems. The study enrolled 53 patients who consumed for 4 weeks a cocktail of 6 bacterial species. The result was that SIBO was resolved in many of the patients but intestinal permeability was not. This led the researchers to conclude that in liver disease patients’ probiotics are effective treatment for SIBO.

Ref: Eur J Gastroenterol Hepatol 2014 Sept 19

http://www.ncbi.nlm.nih.gov/pubmed/25244414

Other blogs you might like

Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.

It is possible that prolonged use of proton pump inhibitors (PPIs) may increase the risk of small intestinal bacterial overgrowth (SIBO). This is...

Read post

Probiotics treatment seems to improve leaky gut syndrome

New findings on shows that probiotics reduce zonulin levels.

Read post

Fructose Malabsoprtion – It is not All or Nothing

People with fructose malabsorption can often just reduce overall fructose intake rather than eliminate fructose all together to get symptom relief.

Read post

Back to all blog posts

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.

Probiotics treatment seems to improve leaky gut syndrome

Fructose Malabsoprtion – It is not All or Nothing

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (13C), nitrogen-15 (15N), deuterium (2H), and oxygen-18 (18O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.

Probiotics treatment seems to improve leaky gut syndrome

Fructose Malabsoprtion – It is not All or Nothing

Get notified on new research technologies

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).